Direct Electrical Stimulation of Central Autonomic Network for Blood Pressure Control: a Mechanism Study
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
The primary objective of this research is to study direct electrical stimulation of central autonomic network for blood pressure control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 22, 2026
CompletedFirst Posted
Study publicly available on registry
September 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
September 28, 2026
December 1, 2025
4 months
September 22, 2026
September 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
blood pressure
Blood Pressure is defined as the blood pressure measurement obtained 30 minutes after the completion of direct electrical stimulation.
up to 4 hours
Study Arms (1)
Direct electrical stimulation
EXPERIMENTALPatients with hypertension and drug-resistant focal epilepsy who underwent intracranial monitoring via stereotactically implanted depth electrodes (SEEG) are assigned to Direct electrical stimulation for 30 sec per mission.
Interventions
The intervention consists of direct electrical stimulation delivered at three distinct frequencies (10 Hz, 50 Hz, and 120 Hz). A double-blind design will be employed to randomly assign one of these frequencies for a 30-second direct electrical stimulation session in each patient.
Eligibility Criteria
You may qualify if:
- Aged 18-60 years, with no gender restrictions.
- Free from severe systemic diseases.
- Patients who have undergone stereoelectroencephalography electrode implantation.
- Patients who have been informed of potential risks, consented to participate in this study, and signed the informed consent form.
- Daytime clinic blood pressure fluctuates within the following range: 90 mmHg \< systolic blood pressure \< 140 mmHg; 60 mmHg \< diastolic blood pressure \< 90 mmHg.
You may not qualify if:
- Patients with scalp electrode hematoma or sub-electrode effusion after intracranial electrode implantation, who are unable to receive electrical stimulation.
- Patients with intracranial structural lesions (e.g., encephalomalacia foci, vascular malformations, space-occupying lesions, etc.).
- Pregnant women.
- Patients who are unable to cooperate due to mental disorders or other causes.
- Patients who have participated in other clinical trials within the past 3 months.
- Patients who apply to withdraw from this clinical trial for any reason.
- Patients with cardiac or pulmonary insufficiency.
- Patients with white coat effect are excluded.
- Patients with low cerebrovascular risk assessed by cranial magnetic resonance imaging (MRI).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liankun Ren, MD
Xuanwu Hospital, Beijing
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 22, 2026
First Posted
September 28, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
September 28, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share